{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:11:42Z","timestamp":1791321102671,"version":"4.3.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The Malaria Policy Advisory Committee to the World Health Organization met in Geneva, Switzerland from 11 to 13 September, 2012. This article provides a summary of the discussions, conclusions and recommendations from that meeting.<\/jats:p>\n          <jats:p>Meeting sessions included: updated policy recommendations on the use of sulphadoxine-pyrimethamine for Intermittent Preventive Treatment of malaria in pregnancy, as well as the use of single dose primaquine as a <jats:italic>Plasmodium falciparum<\/jats:italic> gametocytocide; the need to develop a Global Technical Strategy for Malaria Control and Elimination 2016\u2013 2025 and a global strategy for control of <jats:italic>Plasmodium vivax<\/jats:italic>; the Affordable Medicines Facility for malaria independent evaluation and promoting malaria case management in the private sector; updates from the Technical Expert Group on drug resistance and containment and the Evidence Review Group on malaria burden estimation; update on the RTS,S\/AS01 malaria vaccine; progress on the policy setting process for malaria vector control; and the process for updating the WHO Guidelines for the Treatment of Malaria.<\/jats:p>\n          <jats:p>Policy statements, position statements, and guidelines that arise from the MPAC meeting conclusions and recommendations will be formally issued and disseminated to World Health Organization Member States by the World Health Organization Global Malaria Programme.<\/jats:p>","DOI":"10.1186\/1475-2875-11-424","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T12:45:07Z","timestamp":1356007507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting"],"prefix":"10.1186","volume":"11","author":[{"name":"WHO Malaria Policy Advisory Committee and Secretariat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,19]]},"reference":[{"key":"2631_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1475-2875-11-424","volume":"11","author":"WHO Malaria Policy Advisory Committee and Secretariat","year":"2012","unstructured":"WHO Malaria Policy Advisory Committee and Secretariat: Inaugural meeting of the malaria policy advisory committee to the WHO: conclusions and recommendations. Malar J. 2012, 11: 137-10.1186\/1475-2875-11-137.","journal-title":"Malar J"},{"key":"2631_CR2","unstructured":"Malaria Policy Advisory Committee meeting report series home page. http:\/\/www.malariajournal.com\/series\/WHO_recommendations."},{"key":"2631_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1475-2875-11-28","volume":"11","author":"BJ D\u2019Souza","year":"2012","unstructured":"D\u2019Souza BJ, Newman RD: Strengthening the policy setting process for global malaria control and elimination. Malar J. 2012, 11: 28-10.1186\/1475-2875-11-28.","journal-title":"Malar J"},{"key":"2631_CR4","unstructured":"Malaria Policy Advisory Committee meetings home page. http:\/\/www.who.int\/malaria\/mpac\/mpacmeetings\/en\/index.html."},{"key":"2631_CR5","volume-title":"Departmental Activities and the Global Malaria Landscape, presented on 11","author":"Report from the WHO-GMP Director","year":"2012","unstructured":"Report from the WHO-GMP Director: Departmental Activities and the Global Malaria Landscape, presented on 11. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/mpac_directors_report_sep_2012.pdf., September"},{"key":"2631_CR6","unstructured":"WHO policy recommendation: Seasonal Malaria Chemoprevention (SMC) for P. falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa (March 2012). http:\/\/www.who.int\/malaria\/publications\/atoz\/who_smc_policy_recommendation\/en\/index.html."},{"key":"2631_CR7","unstructured":"WHO position statement \u2013 the role of larviciding for malaria control in sub-Saharan Africa (April 2012). http:\/\/www.who.int\/malaria\/publications\/atoz\/larviciding_position_statement\/en\/index.html."},{"key":"2631_CR8","unstructured":"Global Plan for Insecticide Resistance Management in Malaria Vectors (GPIRM). http:\/\/www.who.int\/malaria\/vector_control\/ivm\/gpirm\/en\/index.html."},{"key":"2631_CR9","unstructured":"Operational Manuals - Disease surveillance for malaria control and elimination. http:\/\/www.who.int\/malaria\/surveillance_monitoring\/operationalmanuals\/en\/index.html."},{"key":"2631_CR10","unstructured":"T3: Test Treat Track Initiative launch page. http:\/\/www.who.int\/malaria\/test_treat_track\/en\/index.html."},{"key":"2631_CR11","unstructured":"WHO case studies on malaria elimination home page. http:\/\/www.who.int\/malaria\/elimination\/casestudies\/en\/index.html."},{"key":"2631_CR12","unstructured":"RAcE. 2015, http:\/\/www.who.int\/malaria\/community_case_management\/en\/index.html., home page"},{"key":"2631_CR13","unstructured":"Malaria. 2012, http:\/\/malaria2012conference.com\/., : Saving Lives in the Asia-Pacific conference home page"},{"key":"2631_CR14","unstructured":"ERG terms of reference: Intermittent Preventive Treatment of malaria in pregnancy using sulphadoxine pyrimethamine. http:\/\/www.who.int\/malaria\/mpac\/mpac_ipt_erg.pdf."},{"key":"2631_CR15","unstructured":"ERG membership: Intermittent Preventive Treatment of malaria in pregnancy using sulphadoxine pyrimethamine. http:\/\/www.who.int\/malaria\/mpac\/members_of_erg_iptp_sp.pdf."},{"key":"2631_CR16","unstructured":"ERG meeting report: Intermittent Preventive Treatment of malaria in pregnancy using sulphadoxine pyrimethamine. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/iptp_sp_erg_meeting_report_july2012.pdf."},{"key":"2631_CR17","unstructured":"ERG update: Intermittent Preventive Treatment of malaria in pregnancy using sulphadoxine pyrimethamine, presented on 11. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/mpac_mip_erg_sep2012.pdf., September"},{"key":"2631_CR18","unstructured":"WHO policy recommendation: Intermittent Preventive Treatment of malaria in pregnancy using sulphadoxine pyrimethamine (October 2012). http:\/\/www.who.int\/malaria\/diagnosis_treatment\/treatment\/who_iptp_sp_policy_recommendation\/en\/index.html."},{"key":"2631_CR19","unstructured":"ERG terms of reference: single dose primaquine as a P. falciparum gametocytocide. http:\/\/www.who.int\/malaria\/mpac\/mpac_primaquine_erg.pdf."},{"key":"2631_CR20","unstructured":"ERG membership: single dose primaquine as a P. falciparum gametocytocide. http:\/\/www.who.int\/malaria\/mpac\/members_of_erg_primaquine.pdf."},{"key":"2631_CR21","unstructured":"ERG meeting report: single dose primaquine as a P. falciparum gametocytocide (August 2012). http:\/\/www.who.int\/malaria\/mpac\/sep2012\/primaquine_single_dose_pf_erg_meeting_report_aug2012.pdf."},{"key":"2631_CR22","unstructured":"ERG update: single dose primaquine as a P. falciparum gametocytocide, presented on 12. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/primaquine_erg_who_mpac.pdf., September"},{"key":"2631_CR23","unstructured":"WHO policy recommendation: single dose primaquine as a P. falciparum gametocytocide (October 2012). http:\/\/www.who.int\/malaria\/diagnosis_treatment\/treatment\/who_pq_policy_recommendation\/en\/index.html."},{"key":"2631_CR24","unstructured":"Developing a malaria strategy mix \u2013 note for MPAC discussion, drafted. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/malaria_strategy_mix_for_2015_2025_sep2012.pdf., September"},{"key":"2631_CR25","unstructured":"Developing a P. vivax global strategy and investment case \u2013 note for MPAC discussion, drafted. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/pvivax_development_global_strategy_and_investment_sep2012.pdf., September"},{"key":"2631_CR26","unstructured":"Briefing on AMFm (WHO-GMP), presented on 13. 2012, http:\/\/www.who.int\/entity\/malaria\/mpac\/sep2012\/amfm_p2_briefing_note_who_gmp_sep2012.pdf., September"},{"key":"2631_CR27","unstructured":"Briefing on AMFm (GF Working Group and RBM Task Force on AMFm), presented on 13. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/amfm_p1_briefing_note_gf_mdag_wg_sep2012.pdf., September"},{"key":"2631_CR28","unstructured":"TEG membership: drug resistance and containment. http:\/\/www.who.int\/malaria\/mpac\/members_of_drc_teg.pdf."},{"key":"2631_CR29","unstructured":"TEG terms of reference: drug resistance and containment. http:\/\/www.who.int\/malaria\/mpac\/feb2012\/drc_teg_tor.pdf."},{"key":"2631_CR30","unstructured":"TEG meeting report: drug resistance and containment (June 2012). http:\/\/www.who.int\/malaria\/mpac\/sep2012\/drc_teg_meeting_report21_22june2012.pdf."},{"key":"2631_CR31","unstructured":"TEG update: drug resistance and containment, presented on 11. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/drc_teg_mpac_sep2012.pdf., September"},{"key":"2631_CR32","unstructured":"ERG terms of reference: malaria burden estimation. http:\/\/www.who.int\/malaria\/mpac\/mpac_burden_erg_tor.pdf."},{"key":"2631_CR33","unstructured":"ERG membership: malaria burden estimation. http:\/\/www.who.int\/malaria\/mpac\/members_of_erg_burden.pdf."},{"key":"2631_CR34","unstructured":"ERG update: malaria burden estimation, presented on 11. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/mbe_erg_update_mpac_sep2012.pdf., September"},{"key":"2631_CR35","unstructured":"ERG meeting report: malaria burden estimation (June 2012). http:\/\/www.who.int\/malaria\/mpac\/sep2012\/mbe_erg_meeting_summary_sep_2012.pdf."},{"key":"2631_CR36","unstructured":"Briefing on RTS,S malaria vaccine for MPAC, drafted. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/breifing_rtss_mpac_sep2012.pdf., August"},{"key":"2631_CR37","unstructured":"JTEG update: RTS,S malaria vaccine, presented on 11. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/jteg_mpac_sep2012.pdf., September"},{"key":"2631_CR38","unstructured":"JTEG terms of reference: malaria vaccines entering pivotal Phase 3 trials and beyond. http:\/\/www.who.int\/vaccine_research\/jteg\/en\/index.html."},{"key":"2631_CR39","unstructured":"Proposed policy setting mechanisms for malaria vector control- note for MPAC discussion, drafted. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/malaria_vector_control_proposed_mechanisms_policy_setting_sep2012.pdf., August"},{"key":"2631_CR40","unstructured":"Policy setting landscape for malaria vector control, presented on 12. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/policy_setting_landscape_for_malaria_vector_control_mpac_sep_2012.pdf., September"},{"key":"2631_CR41","unstructured":"WHO-GMP Technical Expert Groups home page. http:\/\/www.who.int\/malaria\/mpac\/technicalexpertgroups\/en\/index.html."},{"key":"2631_CR42","unstructured":"Malaria chemotherapy TEG draft terms of reference, presented on 12. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/chemotherapy_teg_tor_sept_2012.pdf., September"},{"key":"2631_CR43","unstructured":"TEG terms of reference: malaria chemotherapy. http:\/\/www.who.int\/malaria\/mpac\/chemotherapy_teg_tor.pdf."},{"key":"2631_CR44","unstructured":"Updating the WHO Guidelines for Treatment of Malaria \u2013 note for MPAC discussion, drafted. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/chemotherapy_teg_updating_who_guidelines_treatment_of_malaria_sep2012.pdf., September"},{"key":"2631_CR45","unstructured":"Updating the WHO Guidelines for Treatment of Malaria, presented on 13. 2012, http:\/\/www.who.int\/malaria\/mpac\/sep2012\/chemotherapy_teg_update_mtg_3rd_edition.pdf., September"},{"key":"2631_CR46","unstructured":"MPAC. 2012, http:\/\/www.who.int\/malaria\/mpac\/mpac_list_of_participants_meeting_sep2012.pdf., September meeting list of participants and observers"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-11-424.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:37:37Z","timestamp":1630532257000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-11-424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2631"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-11-424","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"28 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"424"}}